The APRICOT trial is open at centres in locations across the UK.
PPP on the soles of the feet.
A study which is testing a potential new treatment for
palmo-plantar pustulosis (PPP) is looking to recruit 40 new participants to
start as soon as possible. PPP, pustular psoriasis of the palms of the hands
and the soles of the feet, is an uncommon but painful and often debilitating
form of psoriasis.
The study, Anakinra for Pustular Psoriasis: Response in a
Controlled Trial (APRICOT), will test a medication called Anakinra to see if it
improves PPP. The trial also hopes to collect information from participants that
will help to explain how and why people get PPP.
This clinical trial is led by Professor Catherine Smith at
St John’s Institute of Dermatology, and has been funded by the Efficacy and
Mechanism Evaluation (EME) Programme, a Medical Research Council and National
Institute for Health Research partnership. The Psoriasis Association is a
collaborator on the project.
APRICOT is currently open at centres in London, Salford,
Newcastle, Cardiff, Dundee, Bradford, Liverpool, Lancaster, Dudley, Bristol and
Cambridge. The study is also due to open at a centre in Poole very soon.
For more information on the study, including how
to take part in the clinical trial, please visit the APRICOT website